참고문헌
- Tsukahara M, Fujisawa K, Yamamoto K, Hasui M, Saito C, Yamamaka T, et al. Smith-Lemli-Opitz syndrome in Japan. Am J Med Genet 1998;75:118-9. https://doi.org/10.1002/(SICI)1096-8628(19980106)75:1<118::AID-AJMG24>3.0.CO;2-O
- Kelley RI. RSH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. Am J Hum Genet 1998;63:322-6. https://doi.org/10.1086/301987
- Ko JS, Choi BS, Seo JK, Shin JY, Chae JH, Kang GH, et al. A novel DHCR7 mutation in a Smith-Lemli-Opitz syndrome infant presenting with neonatal cholestasis. J Korean Med Sci 2010;25:159-62. https://doi.org/10.3346/jkms.2010.25.1.159
- Jong Hee C, Ki Joong K, Yong Seung H, Ki CS, Kim JW. Identification of a novel DHCR7 mutation in a Korean patient with Smith-Lemli-Opitz syndrome. J Child Neurol 2007;22:1297-300. https://doi.org/10.1177/0883073807307099
- Lee HJ. The Smith-Lemli-Opitz syndrome with a G303R/R352W mutation: in an extremly irritable child responsive to cholesterol supplementation Genes & Genomics 2010;32:9-12. https://doi.org/10.1007/s13258-010-0687-0
- Park MR, Ko JM, Cheon CK, Kim GH, Yoo HW. A case of Smith-Lemli-Opitz syndrome diagnosed by identification of mutations in the 7-dehydrocholesterol reductase (DHCR7) gene. Korean J Pediatr 2008;51:1236-40. https://doi.org/10.3345/kjp.2008.51.11.1236
- Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994;330:107-13. https://doi.org/10.1056/NEJM199401133300205
- Nowaczyk MJ, Irons MB. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 2012;160C:250-62. https://doi.org/10.1002/ajmg.c.31343
- Waterham HR, Hennekam RC. Mutational spectrum of Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet 2012;160C:263-84. https://doi.org/10.1002/ajmg.c.31346
- Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A 1998;95:8181-6. https://doi.org/10.1073/pnas.95.14.8181
- Svoboda MD, Christie JM, Eroglu Y, Freeman KA, Steiner RD. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am J Med Genet C Semin Med Genet 2012;160C:285-94. https://doi.org/10.1002/ajmg.c.31347
- Elias ER, Irons MB, Hurley AD, Tint GS, Salen G. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet 1997;68:305-10. https://doi.org/10.1002/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X
- Haas D, Garbade SF, Vohwinkel C, Muschol N, Trefz FK, Penzien JM, et al. Effects of cholesterol and simvastatin treatment in patients with Smith- Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis 2007;30:375-87. https://doi.org/10.1007/s10545-007-0537-7
- Jira PE, Wevers RA, de Jong J, Rubio-Gozalbo E, Janssen-Zijlstra FS, van Heyst AF, et al. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J Lipid Res 2000;41:1339-46.
- Haas D, Haege G, Hoffmann GF, Burgard P. Prenatal presentation and diagnostic evaluation of suspected Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet A 2013;161A:1008-11.
- Johnson VP. Smith-Lemli-Opitz syndrome: review and report of two affected siblings. Z Kinderheilkd 1975;119:221-34. https://doi.org/10.1007/BF00443506
- Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000;37:321-35. https://doi.org/10.1136/jmg.37.5.321